Jubilant Pharmo

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE700A01033
  • NSEID: JUBLPHARMA
  • BSEID: 530019
INR
933.65
1.4 (0.15%)
BSENSE

Oct 09

BSE+NSE Vol: 2.81 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 525933,
    "name": "Jubilant Pharmo",
    "stock_name": "Jubilant Pharmo",
    "full_name": "Jubilant Pharmova Ltd",
    "name_url": "stocks-analysis/jubilant-pharmo",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "933.65",
    "chg": 1.4,
    "chgp": "0.15%",
    "dir": 1,
    "prev_price": "932.25",
    "mcapval": "14,736.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 530019,
    "symbol": "JUBLPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE700A01033",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "2.81 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/jubilant-pharmo-525933-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 15,
    "sid": "525933",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/jubilant-pharmova-525933"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "05-Oct-2026",
      "details": "Compliance Certificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 for the Quarter ended September 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "29-Sep-2026",
      "details": "Intimation regarding Closure of Trading Window for the Quarter ended September 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Specimen Letter Sent To Shareholders For Withheld Of Dividend For FY 2025-26",
      "datetime": "28-Sep-2026",
      "details": "Specimen letter sent to shareholders for withheld of dividend for FY 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jubilant Pharmova Ltd has declared <strong>500%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Jubilant Pharmova Ltd has announced <strong>1:5</strong> stock split, ex-date: 17 Mar 06",
          "dt": "2006-03-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

05-Oct-2026 | Source : BSE

Compliance Certificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 for the Quarter ended September 30 2026

Closure of Trading Window

29-Sep-2026 | Source : BSE

Intimation regarding Closure of Trading Window for the Quarter ended September 30 2026

Specimen Letter Sent To Shareholders For Withheld Of Dividend For FY 2025-26

28-Sep-2026 | Source : BSE

Specimen letter sent to shareholders for withheld of dividend for FY 2025-26

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Jubilant Pharmova Ltd has declared 500% dividend, ex-date: 24 Jul 26

stock-summary
SPLITS

Jubilant Pharmova Ltd has announced 1:5 stock split, ex-date: 17 Mar 06

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available